DK323281A - Hydantoinderivater og fremgangsmaade i me hydantoinderivater og fremgangsmaade til fremstilling af sam - Google Patents

Hydantoinderivater og fremgangsmaade i me hydantoinderivater og fremgangsmaade til fremstilling af sam

Info

Publication number
DK323281A
DK323281A DK323281A DK323281A DK323281A DK 323281 A DK323281 A DK 323281A DK 323281 A DK323281 A DK 323281A DK 323281 A DK323281 A DK 323281A DK 323281 A DK323281 A DK 323281A
Authority
DK
Denmark
Prior art keywords
procedure
hydantoin derivatives
sam
preparation
hydantoin
Prior art date
Application number
DK323281A
Other languages
English (en)
Other versions
DK157301C (da
DK157301B (da
Inventor
K Ueda
S Tanaka
T Kunii
K Kagei
T Sato
H Ono
I Ohtsuka
M Kawase
T Ohgoh
K I Wakabayashi
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of DK323281A publication Critical patent/DK323281A/da
Publication of DK157301B publication Critical patent/DK157301B/da
Application granted granted Critical
Publication of DK157301C publication Critical patent/DK157301C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK323281A 1980-07-21 1981-07-20 Analogifremgangsmaade til fremstilling af hydantoinderivater og salte deraf DK157301C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9869580 1980-07-21
JP55098695A JPS5745185A (en) 1980-07-21 1980-07-21 Hydantoin derivative and its preparation

Publications (3)

Publication Number Publication Date
DK323281A true DK323281A (da) 1982-02-26
DK157301B DK157301B (da) 1989-12-04
DK157301C DK157301C (da) 1990-05-07

Family

ID=14226632

Family Applications (1)

Application Number Title Priority Date Filing Date
DK323281A DK157301C (da) 1980-07-21 1981-07-20 Analogifremgangsmaade til fremstilling af hydantoinderivater og salte deraf

Country Status (14)

Country Link
US (3) US4540704A (da)
JP (1) JPS5745185A (da)
BE (1) BE889698A (da)
CA (1) CA1167447A (da)
CH (1) CH651568A5 (da)
DE (1) DE3128606A1 (da)
DK (1) DK157301C (da)
ES (1) ES8205398A1 (da)
FR (1) FR2487353B1 (da)
GB (1) GB2080304B (da)
IT (1) IT1194143B (da)
NL (1) NL8103432A (da)
PH (1) PH17460A (da)
SE (1) SE454778B (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
GB2132484B (en) * 1982-12-23 1986-07-02 Tampax Ltd Tampon applicator
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
ATE37371T1 (de) * 1984-08-20 1988-10-15 Pfizer Verfahren zur herstellung asymmetrischer hydantoine.
US5066659A (en) * 1984-10-30 1991-11-19 Pfizer Inc. Spiro-heteroazalones for treatment of diabetic complications
ES8705871A1 (es) * 1984-12-29 1987-05-16 Kaken Pharma Co Ltd Un procedimiento para preparar un derivado de benzofurano
JPH0772190B2 (ja) * 1985-02-26 1995-08-02 エーザイ株式会社 ヒダントイン誘導体
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
US4853410A (en) * 1986-01-17 1989-08-01 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
EP0264586B1 (en) * 1986-08-28 1991-04-03 Sanwa Kagaku Kenkyusho Co., Ltd. Hydantoin derivatives for treating complications of diabetes
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
JP2708507B2 (ja) * 1988-04-07 1998-02-04 株式会社三和化学研究所 （ｄ）‐６‐フルオロ‐２，３‐ジヒドロ‐２’，５’‐ジオキソ‐スピロ［４Ｈ‐１‐ベンゾピラン‐４，４’‐イミダゾリジン］‐２‐カルボキサミド誘導体、これらの製法及び用途
US4987231A (en) * 1989-08-04 1991-01-22 Pfizer Inc. Optical resolution method for 3R-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4R-chromanol
US5164391A (en) * 1989-09-20 1992-11-17 Sanwa Kagaku Kenkyusho Co., Ltd. Hydantoin derivatives for treating complications of diabetes and circulatory diseases
US4980357A (en) * 1990-03-01 1990-12-25 Pfizer Inc. Azolidinedione derivatives
WO1993005045A1 (en) * 1991-08-28 1993-03-18 The Upjohn Company Spirocyclic benzopyran imidazolines
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6539336B1 (en) * 1996-12-12 2003-03-25 Phatrat Technologies, Inc. Sport monitoring system for determining airtime, speed, power absorbed and other factors such as drop distance
US7386401B2 (en) * 1994-11-21 2008-06-10 Phatrat Technology, Llc Helmet that reports impact information, and associated methods
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
SG120054A1 (en) * 1997-04-15 2006-03-28 Csir Appetite suppressant steroidal glycosides
US6077849A (en) * 1998-04-02 2000-06-20 Merck & Co., Inc. Antidiabetic agents
AU754989B2 (en) * 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
GB2355657B (en) * 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
HUP0302555A3 (en) 2000-11-30 2005-06-28 Pfizer Prod Inc Pharmaceutical compositions containing gaba agonists and aldose reductase inhibitors
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
ATE518544T1 (de) 2007-03-12 2011-08-15 Zadec Aps Rotbusch-extrakt gegen diabetes
EP2848252A3 (en) 2007-03-23 2015-06-17 The Board of Regents of the University of Texas System Aldose reductase inhibitors for use in treating uveitis
US20090270490A1 (en) * 2008-04-24 2009-10-29 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibition
WO2010065024A1 (en) * 2008-12-05 2010-06-10 Kador Peter F Topical treatment of cataracts in dogs
EP2406240B1 (en) 2009-03-13 2015-12-23 Vitae Pharmaceuticals, Inc. Inhibitors of beta-secretase
EP2539322B1 (en) 2010-02-24 2014-01-01 Vitae Pharmaceuticals, Inc. Inhibitors of beta-secretase
CN103547261A (zh) 2010-12-23 2014-01-29 德克萨斯大学系统董事会 用于治疗copd的方法
TWI557112B (zh) 2012-03-05 2016-11-11 百靈佳殷格翰國際股份有限公司 β－分泌酶抑制劑
TW201422592A (zh) 2012-08-27 2014-06-16 Boehringer Ingelheim Int β－分泌酶抑制劑
JP2015532282A (ja) 2012-09-28 2015-11-09 ヴァイティー ファーマシューティカルズ，インコーポレイテッド β−セクレターゼの阻害剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US418729A (en) * 1890-01-07 Cultivator
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4147795A (en) * 1977-02-11 1979-04-03 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament

Also Published As

Publication number Publication date
BE889698A (fr) 1982-01-22
DK157301C (da) 1990-05-07
FR2487353B1 (fr) 1986-03-07
DE3128606C2 (da) 1992-04-23
PH17460A (en) 1984-08-29
SE454778B (sv) 1988-05-30
US4540704A (en) 1985-09-10
CA1167447A (en) 1984-05-15
CH651568A5 (de) 1985-09-30
NL8103432A (nl) 1982-02-16
FR2487353A1 (fr) 1982-01-29
ES504103A0 (es) 1982-06-01
ES8205398A1 (es) 1982-06-01
IT8123026A0 (it) 1981-07-20
SE8104456L (sv) 1982-01-22
JPS5745185A (en) 1982-03-13
JPS6332793B2 (da) 1988-07-01
GB2080304B (en) 1984-02-01
US4874869A (en) 1989-10-17
US4780472A (en) 1988-10-25
DK157301B (da) 1989-12-04
IT1194143B (it) 1988-09-14
DE3128606A1 (de) 1982-05-13
GB2080304A (en) 1982-02-03

Similar Documents

Publication Publication Date Title
DK323281A (da) Hydantoinderivater og fremgangsmaade i me hydantoinderivater og fremgangsmaade til fremstilling af sam
DK224781A (da) Imidazo-rifamycin-derivater og fremgangsmaade til fremstilling deraf
DK161581A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK132779A (da) Fremgangsmaade til fremstilling af cishexahydrodibenzoepyranoner og tetrahydrobenzoxoiner
DK100281A (da) Fremgangsmaade til fremstilling af imidazolderivater
NO810351L (no) G imidazolinderivater og fremgangsmaate til deres fremstillin
DK44381A (da) Fremgangsmaade og saet til fremstilling af taage
DK32383D0 (da) Phosphinsyrederivater og fremgangsmade til fremstilling af disse
DK445078A (da) Fremgangsmaade til fremstilling af 4,5-dihydro-2-alkoxycarbonylamino-5-carbocyklisk arylimidazoler og derivater deraf
DK564781A (da) Fremgangsmaade til fremstilling af pyrazoloindazolderivater
DK554581A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK172181A (da) Fremgangsmaade til fremstilling af 9-carbamoyl-9-aminoalkylfluoren-derivater
DK199984D0 (da) Benzoyl-urinstof-derivater med insekticid-virkning og fremgangsmaade til fremstilling af saadanne derivater
DK249179A (da) Fremgangsmaade til fremstilling af 10-deazaaminopterin og dermed beslaegtede forbindelser
DK38493D0 (da) Fremgangsmaade til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
DK565281A (da) Fremgangsmaade til fremstilling af quinolon-derivater
DK85281A (da) Fremgangsmaade til fremstilling af phenoxyderivater
DK448981A (da) Fremgangsmaade til fremstilling af 4-chinolinmethanderivater
DK424781A (da) Fremgangsmaade til fremstilling af quinolonderivater
DK149944C (da) Polymert dispergeringsmiddel og fremgangsmaader til fremstilling af samme
DK551481A (da) Fremgangsmaade til fremstilling af triazolderivater
DK440281A (da) Fremgangsmaade til fremstilling af n-carboxylalkyldipeptider og derivater deraf
DK433381A (da) Fremgangsmaade til fremstilling af 3-brom-4-fluorbenzylalkohol3-brom-4-fluorbenozesyre-derivater og fremgangsmaade til deres fremstilling
DK268981A (da) Fremgangsmaade til fremstilling af adeninnucleosidderivater
DK73579A (da) Nitrosourinstofderivater isaer n1-glucofurasosid 6-yl-n3nitrosourinsoffer og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
PBP Patent lapsed